Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Registrati

INDP Indaptus Therapeutics Inc

0,71

0,0496 (7,51%)

26 Mar 2025 - Chiuso

Dati in Delay di 15 minuti

Form EFFECT - Notice of Effectiveness

Grafico Azioni Indaptus Therapeutics (NASDAQ:INDP)
Storico
Da Feb 2025 a Mar 2025

Clicca qui per i Grafici di Indaptus Therapeutics

Grafico Azioni Indaptus Therapeutics (NASDAQ:INDP)
Storico
Da Mar 2024 a Mar 2025

Clicca qui per i Grafici di Indaptus Therapeutics

Notizie Indaptus Therapeutics Inc - INDP

Indaptus Therapeutics Chief Medical Officer Roger Waltzman, M.D., M.B.A. to Moderate Panel at CMO360 Summit
Martedì 25 Marzo 2025 (15 ore fa) • GlobeNewswire Inc.

Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
Giovedì 20 Marzo 2025 (6 giorni fa) • GlobeNewswire Inc.

Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab
Martedì 18 Marzo 2025 (1 settimana fa) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Venerdì 14 Marzo 2025 (2 settimane fa) • Edgar (US Regulatory)

Form 8-K - Current report
Giovedì 13 Marzo 2025 (2 settimane fa) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Giovedì 13 Marzo 2025 (2 settimane fa) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Giovedì 13 Marzo 2025 (2 settimane fa) • Edgar (US Regulatory)

Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
Giovedì 13 Marzo 2025 (2 settimane fa) • GlobeNewswire Inc.

Registration Is Now Open For Tribe Public’s Webinar Event “Keys To The Kingdom: Unlocking The Power Of Your Immune System” Featuring Indaptus Therapeutics’ CEO On Monday, March 17, 2025
Mercoledì 12 Marzo 2025 (2 settimane fa) • GlobeNewswire Inc.

Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments
Martedì 4 Marzo 2025 (3 settimane fa) • GlobeNewswire Inc.

Indaptus Therapeutics’ Chief Scientific Officer Dr. Michael Newman to Present at the 10th Annual Innate Killer Summit
Martedì 25 Febbraio 2025 (4 settimane fa) • GlobeNewswire Inc.

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mercoledì 12 Febbraio 2025 (1 mese fa) • Edgar (US Regulatory)

Più Indaptus Therapeutics Inc Articoli Notizie

BNP Paribas Issuance

Societe Generale Effekten

It Now IMAT Fundo De Ind...

Global X Autonomous & El...

Mackenzie Canadian Gover...

Romania Fx 5.75% Mar35 Usd

Deferred Settlement Trad...

SG Issuer Sg Issuer Mc J...

Cleveland Cliffs

Hawkley Oil and Gas

Lyxor World Wat

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni